Abstract:International Journal of Biomathematics, Ahead of Print. Drug–target interaction (DTI) is a widely explored topic in the field of bioinformatics and plays a pivotal role in drug discovery. However, the traditional bio-experimental process of drug–target interaction identification requires a large investment of time and labor. To address this challenge, graph neural network (GNN) approaches in deep learning are becoming a prominent trend in the field of DTI research, which is characterized by multimodal processing of data, feature learning and interpretability in DTI. Nevertheless, some methods are still limited by homogeneous graphs and single features. To address the problems, we mechanistically analyze graph convolutional neural networks (GCNs) and graph attentional neural networks (GATs) to propose a new model for the prediction of drug–target interactions using graph neural networks named BiTGNN [Bidirectional Transformer (Bi-Transformer)–graph neural network]. The method first establishes drug–target pairs through the pseudo-position specificity scoring matrix (PsePSSM) and drug fingerprint data, and constructs a heterogeneous network by utilizing the relationship between the drug and the target. Then, the computational extraction of drug and target attributes is performed using GCNs and GATs for the purpose of model information flow extension and graph information enhancement. We collect interaction data using the proposed Bi-Transformer architecture, in which we design a bidirectional cross-attention mechanism for calculating the effects of drug–target interactions for realistic biological interaction simulations. Finally, a feed-forward neural network is used to obtain the feature matrices of the drug and the target, and DTI prediction is performed by fusing the two feature matrices. The Enzyme, Ion Channel (IC), G Protein-coupled Receptor (GPCR) and Nuclear Receptor (NR) datasets are used in the experiments, and compared with several existing mainstream models, our model outperforms in Area Under the ROC Curve (AUC), Specificity, Accuracy and the metric Area Under the Precision–Recall Curve (AUPR).

Heterogeneous Graph Attention Network for Drug-Target Interaction Prediction

Metapath-aggregated heterogeneous graph neural network for drug-target interaction prediction

DTI-HETA: prediction of drug-target interactions based on GCN and GAT on heterogeneous graph

GCHN-DTI: Predicting Drug-Target Interactions by Graph Convolution on Heterogeneous Networks

Drug-Target Interaction Prediction with Graph Attention networks

HGDTI: predicting drug–target interaction by using information aggregation based on heterogeneous graph neural network

A Heterogeneous Network-based Contrastive Learning Approach for Predicting Drug-Target Interaction

Attention-based Cross Domain Graph Neural Network for Prediction of Drug-Drug Interactions.

Identifying drug-target interactions via heterogeneous graph attention networks combined with cross-modal similarities

Drug-Target Prediction Based on Dynamic Heterogeneous Graph Convolutional Network

Heterogeneous Graph Convolutional Network Integrates Multi-modal Similarities for Drug-Target Interaction Prediction

Multi-layer graph attention neural networks for accurate drug-target interaction mapping

IMCHGAN: Inductive Matrix Completion With Heterogeneous Graph Attention Networks for Drug-Target Interactions Prediction

An End-to-end Heterogeneous Graph Representation Learning-Based Framework for Drug-Target Interaction Prediction.

iGRLDTI: An Improved Graph Representation Learning Method for Predicting Drug-Target Interactions over Heterogeneous Biological Information Network

Predicting drug–protein interactions by preserving the graph information of multi source data

NGCN : Drug‐target interaction prediction by integrating information and feature learning from heterogeneous network

BiTGNN: Prediction of drug–target interactions based on bidirectional transformer and graph neural network on heterogeneous graph

A heterogeneous graph neural network with automatic discovery of effective metapaths for drug-target interaction prediction

DMHGNN: Double Multi-View Heterogeneous Graph Neural Network Framework for Drug-Target Interaction Prediction

Drug-Target Interaction Prediction Based on Multi-path Graph Convolution and Graph-Level Attention Mechanism